Earnings calendar

Kymera Therapeutics, Inc. (KYMR) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 3.4% on average (either way), rising 8 times and falling 4. EPS beat estimates 7 of 12 times; revenue 5 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-10-29-1.32-1.26-4.8%1.4M3.3M+3.4%
Q2 FY20262026-08-05-0.62-0.71+13.0%65.0M32.8M+1.9%
Q1 FY20262026-04-30-0.71-0.89+20.2%34.4M8.3M-1.0%
Q4 FY20252026-02-26-0.97-0.78-23.8%2.9M15.0M+0.7%
Q3 FY20252025-11-04-0.90-0.71-26.8%2.8M14.5M+0.3%
Q2 FY20252025-08-11-0.95-0.83-14.5%11.5M17.1M-1.8%
Q1 FY20252025-05-09-0.82-0.92+10.9%22.1M12.4M+4.5%
Q4 FY20242025-02-27-0.88-0.76-15.8%7.4M16.7M-11.3%

KYMR stock report · Earnings calendar